Syngene International Limited has informed the Exchange regarding a press release dated December 01, 2023, titled "Syngene concludes the acquisition of biologics manufacturing facility from Stelis Biopharma Ltd".
Syngene International Limited has informed the Exchange regarding a press release dated December 01, 2023, titled "Syngene concludes the acquisition of biologics manufacturing facility from Stelis Biopharma Ltd".